Shares of Tylenol maker Kenvue Inc. gained more than 5% premarket on Tuesday after a federal court judge in New York ruled that plaintiffs’ expert testimony will be blocked in a case involving product-liability claims against the manufacturers of Tylenol and generic acetaminophen.












